Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_assertion type Assertion NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_head.
- NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_assertion description "[These findings provide evidence that MCL should be very sensitive to targeted therapy aimed at functional inhibition of the cyclin D1/CDK4 complex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_provenance.
- NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_assertion evidence source_evidence_literature NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_provenance.
- NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_assertion SIO_000772 16690963 NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_provenance.
- NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_assertion wasDerivedFrom befree-2016 NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_provenance.
- NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_assertion wasGeneratedBy ECO_0000203 NP549331.RArkMSfBssLX7Ypy34t0mX5hQg-C9_dVecH1izw3aiBvo130_provenance.